MA22749A1 - Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
MA22749A1
MA22749A1 MA23040A MA23040A MA22749A1 MA 22749 A1 MA22749 A1 MA 22749A1 MA 23040 A MA23040 A MA 23040A MA 23040 A MA23040 A MA 23040A MA 22749 A1 MA22749 A1 MA 22749A1
Authority
MA
Morocco
Prior art keywords
hydroxylamino
oxoethyl
carbonyl
amino
methyl
Prior art date
Application number
MA23040A
Other languages
English (en)
French (fr)
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of MA22749A1 publication Critical patent/MA22749A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
MA23040A 1991-12-23 1992-12-22 Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant MA22749A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
MA22749A1 true MA22749A1 (fr) 1993-07-01

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23040A MA22749A1 (fr) 1991-12-23 1992-12-22 Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (26)

Country Link
EP (1) EP0575572A1 (lv)
JP (1) JPH06506002A (lv)
CN (1) CN1079474A (lv)
AU (1) AU657591B2 (lv)
BG (1) BG98050A (lv)
BR (1) BR9205652A (lv)
CA (1) CA2104372A1 (lv)
CZ (1) CZ379692A3 (lv)
EE (1) EE9400006A (lv)
FI (1) FI933685A (lv)
HR (1) HRP921454A2 (lv)
HU (1) HUT69287A (lv)
IT (1) IT1252708B (lv)
LV (1) LV10426B (lv)
MA (1) MA22749A1 (lv)
MX (1) MX9207543A (lv)
NZ (1) NZ245547A (lv)
PL (1) PL169086B1 (lv)
PT (1) PT101156A (lv)
RU (1) RU2079489C1 (lv)
SI (1) SI9200409A (lv)
SK (1) SK379692A3 (lv)
TN (1) TNSN92117A1 (lv)
WO (1) WO1993013056A1 (lv)
YU (1) YU110892A (lv)
ZA (1) ZA9210004B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
EP2079304A4 (en) * 2006-09-28 2010-01-06 Merck & Co Inc AMINBASE SALTS FROM SAHA AND POLYMORPHE DAVON
US20210332635A1 (en) * 2020-04-27 2021-10-28 Carter-Hoffmann LLC Door movement system for cabinet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
HU9302389D0 (en) 1993-11-29
ITMI913448A0 (it) 1991-12-23
LV10426A (lv) 1995-02-20
PL297118A1 (en) 1993-09-06
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
JPH06506002A (ja) 1994-07-07
TNSN92117A1 (fr) 1993-06-08
EE9400006A (et) 1995-12-15
WO1993013056A1 (en) 1993-07-08
BG98050A (bg) 1994-04-29
FI933685A0 (fi) 1993-08-20
SK379692A3 (en) 1995-04-12
FI933685A (fi) 1993-08-20
HUT69287A (en) 1995-09-28
BR9205652A (pt) 1994-05-03
ZA9210004B (en) 1993-12-13
CN1079474A (zh) 1993-12-15
EP0575572A1 (en) 1993-12-29
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
ITMI913448A1 (it) 1993-06-23
HRP921454A2 (en) 1995-02-28
MX9207543A (es) 1993-08-01
RU2079489C1 (ru) 1997-05-20
PT101156A (pt) 1994-06-30
CA2104372A1 (en) 1993-06-24
CZ379692A3 (en) 1993-09-15
IT1252708B (it) 1995-06-26
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
AU657591B2 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
MA26571A1 (fr) Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26620A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24469A1 (fr) Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA26675A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2665898B1 (fr) Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2595351B1 (fr) Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2553099B1 (fr) Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA24832A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydropyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26519A1 (fr) Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26603A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26552A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
PT77226A (fr) Procede pour preparer derives d'acides omega-amines et compositions contenant ces derives
BE895269A (fr) Sel d'acide (+)-2-(2-fluoro-4-biphenylyl)- propionique, procede pour sa preparation et composition pharmaceutique le contenant
MA22749A1 (fr) Sels stables d'acide de (+)-(15,2r)-2-(n-2 hydroxylamino -2-oxoethyl) -n-methyl-amino) carbonyl) cyclo hexane -1-carboxylique; procede pour leur preparation et compositions pharmaceutiques les contenant
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2726267B1 (fr) Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
DZ3047A1 (fr) Sel mutuel d'amlopidine et d'atorvastatine, procédé pour sa préparation et compositions pharmaceutiques les contenant.